Boston Scientific Corp

NYSE:BSX

Mr. Michael F. Mahoney

Chairman, President & CEO

Michael F. Mahoney is a prominent figure in the medical device industry, currently serving as the CEO and Chairman of Boston Scientific Corporation, a global leader in developing and manufacturing medical devices used across a range of interventional medical specialties. Mahoney joined Boston Scientific in 2011 as President and became CEO in November 2012. He was appointed Chairman in May 2016. Under his leadership, Boston Scientific has expanded its product portfolio and entered new markets, significantly enhancing its research and development capabilities. Mahoney has focused on building a high-performance culture and prioritizing innovation to drive company growth and improve patient outcomes. Before his tenure at Boston Scientific, Mahoney held various senior leadership roles in other major healthcare companies. He was the Worldwide Chairman of the Medical Devices and Diagnostics Group at Johnson & Johnson, where he played a key role in the company's extensive medical device business. Earlier in his career, he held significant positions at GE Healthcare, including President and CEO of GE Healthcare's Technologies division, and at Covidien, serving as President of the company. Mahoney is known for his strategic thinking and commitment to corporate social responsibility. He has been instrumental in fostering a company culture that values diversity, equity, and inclusion. His efforts have contributed to Boston Scientific's reputation as a leader in the healthcare industry, both in terms of business success and social responsibility.

Daniel J. Brennan is the Executive Vice President and Chief Financial Officer of Boston Scientific Corporation, a global medical technology leader. As CFO, he is responsible for overseeing the company's global finance, corporate strategy and development, information technology, and business development functions. Brennan joined Boston Scientific in 1996 and has held various roles with increasing responsibility over the years. Before becoming CFO in 2014, he served as the Senior Vice President of Finance and Treasurer. In that role, he was responsible for global controllership, corporate finance, and tax functions, and he played a key role in the company's capital structure management and financial strategy. He holds a Bachelor of Science degree in Finance and Investments and a Master of Business Administration from Babson College. As a certified public accountant (CPA), Brennan brings a wealth of financial expertise and leadership experience to his role at Boston Scientific.

Mr. Joseph M. Fitzgerald

Executive VP & Group President of Cardiology

Joseph M. Fitzgerald is a prominent figure in the medical device industry, known for his leadership role at Boston Scientific Corporation. He has held several significant positions within the company, most notably as Executive Vice President and President of the Rhythm Management group. In this role, he was responsible for overseeing the development and commercialization of products related to managing heart rhythm disorders, a critical area in cardiac healthcare. Fitzgerald joined Boston Scientific in 1990 and has contributed to numerous advancements and strategic initiatives within the company. His work has been instrumental in driving innovation, expanding market reach, and strengthening the company's position in the medical technology sector. His leadership has been characterized by a focus on expanding product lines and improving patient outcomes, aligning with Boston Scientific's overall mission to transform lives through innovative medical solutions.

Mr. Jeffrey B. Mirviss M.B.A.

Executive VP & President of Peripheral Interventions

Jeffrey B. Mirviss is a prominent executive at Boston Scientific Corporation, where he has made significant contributions to the company's success. He serves as the Executive Vice President and President of the Peripheral Interventions (PI) division. Since joining Boston Scientific in 1997, Mirviss has held various leadership roles, bringing extensive experience and vision to the organization. Mirviss is responsible for overseeing the development and execution of strategies that drive innovation and growth within the Peripheral Interventions division, which focuses on providing advanced medical solutions for peripheral vascular disease, deep vein thrombosis, and other vascular conditions. Under his leadership, the division has expanded its product portfolio and strengthened its market position. Before his current role, Mirviss held several key positions within Boston Scientific, including Senior Vice President and President of the Peripheral Interventions division. His career has been characterized by a strong emphasis on product innovation, strategic marketing, and business development. Mirviss holds an M.B.A., which has equipped him with strong business acumen and strategic insights that have been instrumental in navigating the complexities of the medical device industry. His leadership and commitment to improving patient care continue to drive Boston Scientific's efforts to deliver cutting-edge solutions to the healthcare community.

Arthur Crosswell Butcher is a notable figure at Boston Scientific Corporation, where he is known for his executive leadership. Butcher serves as the Executive Vice President and President of the MedSurg division, which encompasses Endoscopy and Urology and Pelvic Health. Boston Scientific, a global leader in the medical device industry, benefits from his extensive experience and strategic vision. Butcher's career at Boston Scientific has been marked by progressive leadership roles, where he has overseen vital business segments, contributing to growth and innovation. His expertise in the medical technology sector is supported by a deep understanding of product development, marketing strategies, and operational leadership. He has been instrumental in driving initiatives that expand the company's product offerings and market reach, ultimately enhancing patient outcomes globally. His leadership style is characterized by a focus on collaboration, innovation, and a commitment to improving healthcare solutions. Through his stewardship, the MedSurg division continues to advance in its mission of delivering minimally invasive technologies that improve patients' lives.

John Bradley Sorenson serves as the Executive Vice President, Global Operations at Boston Scientific Corporation. He has been with the company since 1994 and has held various leadership positions within the organization. Before his current role, Sorenson was responsible for the company's manufacturing, supply chain, distribution, and logistics operations worldwide. Under his leadership, Boston Scientific has focused on optimizing productivity, enhancing quality, and improving global operations efficiency. Sorenson's extensive background in operations and his long tenure with Boston Scientific have contributed to the company's strong global manufacturing and supply chain strategies. He holds a bachelor's degree in finance from the University of Utah and an MBA from Harvard Business School. His leadership style emphasizes collaboration and continuous improvement, aligning with the company's commitment to delivering high-quality medical solutions across the globe.

Jonathan R. Monson is the Chief Compliance Officer at Boston Scientific Corporation. In his role, he is responsible for overseeing the company’s global compliance efforts and ethics programs, ensuring they align with legal standards and industry regulations. Monson plays a pivotal role in reinforcing Boston Scientific's commitment to conducting its business with integrity and ethical standards. With a background in law and extensive experience in corporate compliance, he has previously worked in various capacities that contribute to his expertise in managing compliance risks and developing comprehensive compliance strategies. Monson's leadership and proactive approach help foster a culture of compliance and ethical behavior within the organization.

Vance R. Brown is an accomplished executive known for his work with Boston Scientific Corporation, a global medical technology company that develops and manufactures a wide array of devices used in various interventional medical specialties. Mr. Brown has served in various leadership roles at Boston Scientific, contributing significantly to the company's strategic direction and operational execution. His diverse experience in the medical device industry has enabled him to drive growth and innovation, ensuring that Boston Scientific remains at the forefront of medical technology. His leadership style is often described as results-driven and visionary, focusing on both current operational excellence and long-term strategic planning. This dual focus helps Boston Scientific to maintain its competitive edge and continue to develop groundbreaking solutions that improve patient outcomes around the world. Within the industry, he is recognized for his deep understanding of both the business and technical aspects of medical devices, making him a valuable asset to Boston Scientific and the field at large. Mr. Brown's contributions extend beyond corporate leadership to include active involvement in industry associations and initiatives aimed at advancing healthcare technology and innovation. Under his guidance, Boston Scientific has continued to advance its mission of transforming lives through innovative medical solutions, demonstrating the profound impact of effective leadership in the dynamic field of medical technology.

Mary Beth Moynihan is a highly regarded executive at Boston Scientific Corporation, an American manufacturer of medical devices. She has played a significant role within the company, particularly in areas relating to marketing and communications. Moynihan joined Boston Scientific in 1997 and has since held various leadership positions, showcasing her expertise in strategic planning and management. Over the years, she has contributed significantly to the company's growth and brand development through her leadership in global marketing and strategy. Her role often involves overseeing marketing communications, brand management, and corporate communications. This includes developing and implementing strategies to enhance the company's reputation and its engagement with healthcare professionals and patients. Moynihan is known for her strategic vision and her ability to drive company initiatives that align with Boston Scientific's goals of advancing science for life. Her extensive experience and contributions have made her a pivotal part of Boston Scientific’s leadership team.